Stevanato Group SpA (STVN) is a Healthcare · Medical Instruments & Supplies company listed on NYSE. Price $21.99 (-3.00%), Market cap $4.91B, P/E ratio 29.98, 52-week low–high $13.43 ~ $27.95.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspe
Financial statements, price targets, institutional (13F) holdings and related news for Stevanato Group SpA are updated in real time on BlackAll Trade.
Stevanato Group SpA trades at $21.99 (-3.00%). Real-time quotes and charts are available on BlackAll Trade.
Stevanato Group SpA has a market cap of about $4.91B. Its P/E ratio is 29.98.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, No